Skip to main content
. 2015 Jan 14;21(2):511–516. doi: 10.3748/wjg.v21.i2.511

Figure 1.

Figure 1

Differential expression of microRNA-103 levels in the serum of patients with nonalcoholic fatty liver disease. microRNA (miR)-103 was log-transformed before analysis because it was not normally distributed. aP < 0.05 vs normal control group (unpaired Student t test). NAFLD: Nonalcoholic fatty liver disease.